Vitamin D hormone: A multitude of actions potentially influencing the physical function decline in older persons

Geriatrics and Gerontology International

Volumn 11, Issue 2, 2011, Pages 133-142

  Cesari, Matteo ^a,b   Incalzi, Raffaele Antonelli ^a   Zamboni, Valentina ^b   Pahor, Marco ^c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Sacro Cuore Hospice   (Italy)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Physical function; Sarcopenia; Skeletal muscle; Vitamin D

Indexed keywords

CALCIFEDIOL; CALCITRIOL; VITAMIN D; VITAMIN D RECEPTOR;

ACTION POTENTIAL; BODY COMPOSITION; CLINICAL RESEARCH; HORMONE BLOOD LEVEL; HUMAN; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PHYSICAL DISEASE BY BODY FUNCTION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKELETAL MUSCLE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

AGING; HUMANS; MUSCLE, SKELETAL; SARCOPENIA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79952717976     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2010.00668.x     Document Type: Review

References (120)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
2. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80: 1689S-1696S.
3. Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics 2003; 112: e132-e135.
4. A dose of vitamin D history. Nat Struct Biol 2002; 9: 77.
5. Gloth FM 3rd, Gundberg CM, Hollis BW, Haddad JGJ, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA 1995; 274: 1683-1686.
6. Goldray D, Mizrahi-Sasson E, Merdler C etal. Vitamin D deficiency in elderly patients in a general hospital. J Am Geriatr Soc 1989; 37: 589-592.
7. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992; 93: 69-77.
8. Wicherts IS, van Schoor NM, Boeke AJ etal. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007; 92: 2058-2065.
9. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79: 362-371.
10. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-1956.
11. Annweiler C, Schott AM, Berrut G, Fantino B, Beauchet O. Vitamin D-related changes in physical performance: a systematic review. J Nutr Health Aging 2009; 13: 893-898.
12. Annweiler C, Bridenbaugh S, Schott AM, Berrut G, Kressig RW, Beauchet O. Vitamin D and muscle function: new prospects? [Letter]. Biofactors 2009; 35 (1): 3-4.
13. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998; 78: 1193-1231.
14. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009; 19: 73-78.
15. Office of Dietary Supplements, National Institutes of Health. Dietary supplement fact sheet: vitamin D. [Cited 22 Oct 2010.] Available from URL.
16. Nutrient Laboratoy Data, United States Department of Agruculture (USDA). Nutrient database for standard reference. [Cited 22 Oct 2010.] Available from URL.
17. Chen TC, Chimeh F, Lu Z etal. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 2007; 460: 213-217.
18. Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 2008; 87: 1738-1742.
19. Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating vitamin D3 and 25-hydroxyvitamin D in humans: an important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol 2007; 103: 631-634.
20. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77: 204-210.
21. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006; 92: 4-8.
22. Cannell JJ, Hollis BW, Zasloff M, Heaney RP. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 2008; 9: 107-118.
23. Vieth R. Why "vitamin D" is not a hormone, and not a synonym for 1, 25-dihydroxy-vitamin D, its analogs or deltanoids. J Steroid Biochem Mol Biol 2004; 89-90: 571-573.
24. Adams JS, Chen H, Chun R etal. Response element binding proteins and intracellular vitamin D binding proteins: novel regulators of vitamin D trafficking, action and metabolism. J Steroid Biochem Mol Biol 2004; 89-90: 461-465.
25. Peng L, Malloy PJ, Feldman D. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Mol Endocrinol 2004; 18: 1109-1119.
26. Nemere I. 24, 25-dihydroxyvitamin D3 suppresses the rapid actions of 1, 25-dihydroxyvitamin D3 and parathyroid hormone on calcium transport in chick intestine. J Bone Miner Res 1999; 14: 1543-1549.
27. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 2008; 29: 407-414.
28. Capiati D, Benassati S, Boland RL. 1, 25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J Cell Biochem 2002; 86: 128-135.
29. Hopkinson NS, Li KW, Kehoe A etal. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr 2008; 87: 385-390.
30. Roth SM, Zmuda JM, Cauley JA, Shea PR, Ferrell RE. Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol A Biol Sci Med Sci 2004; 59: 10-15.
31. Grundberg E, Brandstrom H, Ribom EL, Ljunggren O, Mallmin H, Kindmark A. Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur J Endocrinol 2004; 150: 323-328.
32. Maggio D, Cherubini A, Lauretani F etal. 25(OH)D Serum levels decline with age earlier in women than in men and less efficiently prevent compensatory hyperparathyroidism in older adults. J Gerontol A Biol Sci Med Sci 2005; 60: 1414-1419.
33. Rucker D, Allan JA, Fick GH, Hanley DA. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 2002; 166: 1517-1524.
34. Webb AR, Pilbeam C, Hanafin N, Holick MF. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 1990; 51: 1075-1081.
35. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004; 80: 1678S-1688S.
36. Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982; 1: 74-76.
37. Lee P, Campbell LV. Vitamin D deficiency: the invisible accomplice of metabolic endotoxemia? Curr Pharm Des 2009; 15: 2751-2758.
38. Mehrotra R, Kermah D, Budoff M etal. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1144-1151.
39. Hayes DP. Vitamin D and ageing. Biogerontology 2010; 11: 1-16.
40. Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1, 25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 1992; 75: 176-182.
41. Duque G, El Abdaimi K, Macoritto M, Miller MM, Kremer R. Estrogens (E2) regulate expression and response of 1, 25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation. Biochem Biophys Res Commun 2002; 299: 446-454.
42. Lund B, Sorensen OH, Lund B, Agner E. Serum 1, 25-dihydroxyvitamin D in normal subjects and in patients with postmenopausal osteopenia. Influence of age, renal function and oestrogen therapy. Horm Metab Res 1982; 14: 271-274.
43. Elkeles A. A comparative radiological study of calcified atheroma in males and females over 50 years of age. Lancet 1957; 273: 714-715.
44. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289: F8-28.
45. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662-687.
46. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730-1737.
47. Norman PE, Powell JT. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol 2005; 25: 39-46.
48. Xiang W, Kong J, Chen S etal. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005; 288: E125-E132.
49. Pilz S, Tomaschitz A, Drechsler C, Dekker JM, Marz W. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res 2010; 2010: 11103-1113.
50. Wang TJ, Pencina MJ, Booth SL etal. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-511.
51. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008; 168: 1174-1180.
52. Dobnig H, Pilz S, Scharnagl H etal. Independent association of low serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-1349.
53. Landfield PW, Cadwallader-Neal L. Long-term treatment with calcitriol (1, 25(OH)2 vit D3) retards a biomarker of hippocampal aging in rats. Neurobiol Aging 1998; 19: 469-477.
54. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13: 100-105.
55. Wilkins CH, Birge SJ, Sheline YI, Morris JC. Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. J Natl Med Assoc 2009; 101: 349-354.
56. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006; 14: 1032-1040.
57. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838.
58. Kragt J, van Amerongen B, Killestein J etal. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 2009; 15: 9-15.
59. van der Mei IA, Ponsonby AL, Dwyer T etal. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 2007; 254: 581-590.
60. Ekbom K, Hed R, Kirstein L, Astroem KE. Weakness of proximal limb muscles, probably due to myopathy after gastrectomy. Preliminary report. Acta Med Scand 1964; 176: 493-496.
61. Smith R, Stern G. Myopathy, osteomalacia and hyperparathyroidism. Brain 1967; 90: 593-602.
62. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007; 56: 2143-2149.
63. Moro JR, Iwata M, von Andriano UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8: 685-698.
64. Liu PT, Stenger S, Li H etal. Toll-like receptor triggering of a vitamin d-mediated human antimicrobial response. Science 2006; 311: 1770-1773.
65. Minasyan A, Keisala T, Zou J etal. Vestibular dysfunction in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 2009; 114: 161-166.
66. McGrath J, Selten JP, Chant D. Long-term trends in sunshine duration and its association with schizophrenia birth rates and age at first registration - data from Australia and the Netherlands. Schizophr Res 2002; 54: 199-212.
67. Gloth FM 3rd, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999; 3: 5-7.
68. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
69. Davis CD. Vitamin D and cancer: current dilemmas and future research needs. Am J Clin Nutr 2008; 88: 565S-569S.
70. Gorkin Z, Gorkin MJ, Teslenko NE. [The effect of ultraviolet irradiation upon training for 100m sprint]. Fiziol Zh USSR 1938; 25: 695-701.
71. Parade GW, Otto H. [Effect of sunlamp on performance]. Z Klin Med 1940; 137: 17-21.
72. Floyd M, Ayyar DR, Barwick DD, Hudgson P, Weightman D. Myopathy in chronic renal failure. Q J Med 1974; 43: 509-524.
73. Irani PF. Electromyography in nutritional osteomalacic myopathy. J Neurol Neurosurg Psychiatry 1976; 39: 686-693.
74. Prabhala A, Garg R, Dandona P. Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med 2000; 160: 1199-1203.
75. Mingrone G, Greco AV, Castagneto M, Gasbarrini G. A woman who left her wheelchair. Lancet 1999; 353: 806.
76. Russell JA. Osteomalacic myopathy. Muscle Nerve 1994; 17: 578-580.
77. Simpson RU, Thomas GA, Arnold AJ. Identification of 1, 25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 1985; 260: 8882-8891.
78. Bischoff HA, Borchers M, Gudat F etal. In situ detection of 1, 25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001; 33: 19-24.
79. Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004; 19: 265-269.
80. Endo I, Inoue D, Mitsui T etal. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003; 144: 5138-5144.
81. Yoshikawa S, Nakamura T, Tanabe H, Imamura T. Osteomalacic myopathy. Endocrinol Jpn 1979; 26: 65-72.
82. Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 2005; 20: 187-192.
83. Sorensen OH, Lund B, Saltin B etal. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci 1979; 56: 157-161.
84. Schott GD, Wills MR. Muscle weakness in osteomalacia. Lancet 1976; 1: 626-629.
85. Prineas JW, Mason AS, Henson RA. Myopathy in metabolic bone disease. Br Med J 1965; 1: 1034-1036.
86. Faulkner KA, Cauley JA, Zmuda JM etal. Higher 1, 25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int 2006; 17: 1318-1328.
87. Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 2006; 91: 2980-2985.
88. Pfeifer M, Begerow B, Minne HW etal. Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 2001; 109: 87-92.
89. Flicker L, Mead K, MacInnis RJ etal. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 2003; 51: 1533-1538.
90. Bischoff HA, Stahelin HB, Dick W etal. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003; 18: 343-351.
91. Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007; 55: 234-239.
92. Flicker L, MacInnis RJ, Stein MS etal. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 2005; 53: 1881-1888.
93. Latham NK, Anderson CS, Lee A, Bennett DA, Moseley A, Cameron ID. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS). J Am Geriatr Soc 2003; 51: 291-299.
94. Sanders KM, Stuart AL, Williamson EJ etal. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815-1822.
95. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC etal. Effect of vitamin D on falls: a meta-analysis. JAMA 2004; 291: 1999-2006.
96. Jackson C, Gaugris S, Sen SS, Hosking D. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. QJM 2007; 100: 185-192.
97. Latham NK, Anderson CS, Reid IR. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review. J Am Geriatr Soc 2003; 51: 1219-1226.
98. Bischoff-Ferrari HA, Dietrich T, Orav EJ etal. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged >or =60y. Am J Clin Nutr 2004; 80: 752-758.
99. Mowe M, Haug E, Bohmer T. Low serum calcidiol concentration in older adults with reduced muscular function. J Am Geriatr Soc 1999; 47: 220-226.
100. Houston DK, Cesari M, Ferrucci L etal. Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2007; 62: 440-446.
101. Zamboni M, Zoico E, Tosoni P etal. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol A Biol Sci Med Sci 2002; 57: M7-11.
102. Semba RD, Garrett E, Johnson BA, Guralnik JM, Fried LP. Vitamin D deficiency among older women with and without disability. Am J Clin Nutr 2000; 72: 1529-1534.
103. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int 2005; 16: 1425-1431.
104. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003; 88: 5766-5772.
105. Dam TT, von Muhlen D, Barrett-Connor EL. Sex-specific association of serum vitamin D levels with physical function in older adults. Osteoporos Int 2009; 20: 751-760.
106. Verreault R, Semba RD, Volpato S, Ferrucci L, Fried LP, Guralnik JM. Low serum vitamin D does not predict new disability or loss of muscle strength in older women. J Am Geriatr Soc 2002; 50: 912-917.
107. Lips P, Binkley N, Pfeifer M etal. Once-weekly dose of 8400IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J Clin Nutr 2010; 91: 985-991.
108. Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 2002; 75: 611-615.
109. Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women - a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 2007; 46: 1852-1857.
110. Dawson-Hughes B, Harris SS. High-dose vitamin D supplementation: too much of a good thing? JAMA 2010; 303: 1861-1862.
111. Kinder BK, Stewart AF. Hypercalcemia. Curr Probl Surg 2002; 39: 349-448.
112. Akishita M, Arai H, Arai H etal. Survey on geriatricians' experiences of adverse drug reactions caused by potentially inappropriate medications: Commission report of the Japan Geriatrics Society. Geriatr Gerontol Int 2010; doi: 10.1111/j.1447-0594.2010.00631.x.
113. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135: 317-322.
114. Heaney RP. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005; 97: 13-19.
115. Adams JS, Lee G. Gains in bone mineral density with resolution of vitamin D intoxication. Ann Intern Med 1997; 127: 203-206.
116. Koutkia P, Chen TC, Holick MF. Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med 2001; 345: 66-67.
117. Cheng S, Tylavsky F, Kroger H etal. Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls. Am J Clin Nutr 2003; 78: 485-492.
118. Tylavsky FA, Ryder KA, Lyytikainen A, Cheng S. Vitamin D, parathyroid hormone, and bone mass in adolescents. J Nutr 2005; 135: 2735S-2738S.
119. Chapuy MC, Preziosi P, Maamer M etal. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997; 7: 439-443.
120. Thomas MK, Lloyd-Jones DM, Thadhani RI etal. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-783.